Latest Period
Q4 2025
Security Snapshot
RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share (RIGL) Institutional Ownership
CUSIP: 766559702
13F Institutional Holders and Ownership History from Q2 2024 to Q1 2026
Institutions Reporting
185
Shares (Excl. Options)
16,094,279
Price
$42.83
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Symbol
- RIGL on Nasdaq
- Shares outstanding
- 18,617,462
- Price per share
- $28.73
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 16,094,279
- Total reported value
- $688,576,820
- % of total 13F portfolios
- 0%
- Share change
- +1,123,145
- Value change
- +$63,536,235
- Number of holders
- 185
- Price from insider filings
- $28.73
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- RIGL - RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share is tracked under CUSIP 766559702.
- 185 institutions reported positions in Q4 2025.
- 6 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 185 to 48 between Q4 2025 and Q1 2026.
- Reported value moved from $688,576,820 to $78,502,848.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 185 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 766559702?
CUSIP 766559702 identifies RIGL - RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 766559702:
Significant Owners of RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share (RIGL) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 8.5% | +28% | $28,894,960 | +$6,937,840 | 1,516,000 | +32% | Armistice Capital, LLC | 31 Mar 2025 |
| BlackRock, Inc. | 7.7% | -22% | $26,340,596 | -$6,978,323 | 1,381,983 | -21% | BlackRock, Inc. | 31 Mar 2025 |
| STATE STREET CORP | 6% | $45,645,858 | 1,091,223 | STATE STREET CORPORATION | 31 Dec 2025 | |||
| Soleus Capital Master Fund, L.P. | 5.2% | +38% | $27,813,743 | +$8,905,237 | 968,108 | +47% | Soleus Capital Master Fund, L.P. | 06 May 2026 |
| MORGAN STANLEY | 0.7% | $3,297,817 | 116,406 | Morgan Stanley | 30 Sep 2025 | |||
| Invesco Ltd. | 0% | $122,918 | 6,449 | Invesco Ltd. | 31 Dec 2024 |
As of 31 Dec 2025, 185 institutional investors reported holding 16,094,279 shares of RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share (RIGL). This represents 86% of the company’s total 18,617,462 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share (RIGL) together control 66% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.9% | 1,664,210 | -3.5% | 0% | $71,278,114 |
| STATE STREET CORP | 5.9% | 1,091,223 | +97% | 0% | $46,737,081 |
| VANGUARD GROUP INC | 5.6% | 1,038,408 | -0.45% | 0% | $44,475,015 |
| ARMISTICE CAPITAL, LLC | 4.5% | 836,000 | +15% | 0.88% | $35,805,880 |
| GOLDMAN SACHS GROUP INC | 3.6% | 671,878 | -8.8% | 0% | $28,776,535 |
| MARSHALL WACE, LLP | 3.3% | 613,600 | +2% | 0.03% | $26,280,489 |
| LSV ASSET MANAGEMENT | 2.9% | 544,282 | +391% | 0.05% | $23,312,000 |
| RENAISSANCE TECHNOLOGIES LLC | 2.9% | 539,009 | +14% | 0.04% | $23,085,755 |
| ACADIAN ASSET MANAGEMENT LLC | 2.7% | 493,604 | -28% | 0.03% | $21,132,000 |
| MILLENNIUM MANAGEMENT LLC | 2.3% | 431,460 | +310% | 0.01% | $18,479,432 |
| D. E. Shaw & Co., Inc. | 2.3% | 424,316 | +38% | 0.01% | $18,173,454 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 424,314 | +0.14% | 0% | $18,177,612 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.2% | 413,659 | +122% | 0.01% | $17,717,015 |
| Soleus Capital Management, L.P. | 1.6% | 300,034 | -9.1% | 0.55% | $12,850,456 |
| Qube Research & Technologies Ltd | 1.5% | 288,269 | -20% | 0.02% | $12,346,561 |
| Hillsdale Investment Management Inc. | 1.5% | 282,584 | -0.64% | 0.33% | $12,103,074 |
| DIMENSIONAL FUND ADVISORS LP | 1.5% | 276,812 | +32% | 0% | $11,855,857 |
| JANE STREET GROUP, LLC | 1.5% | 275,883 | -14% | 0.01% | $11,816,069 |
| TWO SIGMA INVESTMENTS, LP | 1.5% | 271,228 | +23% | 0.02% | $11,616,695 |
| Nuveen, LLC | 1.4% | 258,893 | +94% | 0% | $11,088,387 |
| AMERICAN CENTURY COMPANIES INC | 1.4% | 254,492 | 0.01% | $10,899,892 | |
| CM Management, LLC | 1.2% | 225,000 | 0% | 8.1% | $9,636,750 |
| GLOBEFLEX CAPITAL L P | 1.2% | 217,839 | +0.1% | 1.4% | $9,330,044 |
| Trexquant Investment LP | 1.1% | 197,148 | +18% | 0.08% | $8,443,849 |
| CITADEL ADVISORS LLC | 1% | 185,419 | +114% | 0.01% | $7,941,496 |
Institutional Holders of RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share (RIGL) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 2,903,668 | $78,502,848 | -$5,182,187 | $27.04 | 48 |
| 2025 Q4 | 16,094,279 | $688,576,820 | +$63,536,235 | $42.83 | 185 |
| 2025 Q3 | 14,989,035 | $424,666,568 | +$32,448,563 | $28.33 | 164 |
| 2025 Q2 | 13,883,445 | $260,032,689 | +$336,299 | $18.73 | 121 |
| 2025 Q1 | 13,902,025 | $250,095,419 | +$32,047,743 | $17.99 | 118 |
| 2024 Q4 | 12,067,467 | $202,977,408 | +$2,514,731 | $16.82 | 114 |
| 2024 Q3 | 11,904,852 | $192,606,131 | +$27,253,219 | $16.18 | 87 |
| 2024 Q2 | 10,378,502 | $85,309,593 | +$85,148,446 | $8.22 | 80 |